Ramaswamy Suvasini et al reported that IGF2BP3 as a glioblastoma‐specific pro‐proliferative and pro‐invasive marker acting through IGF‐2 resulting in the activation of oncogenic PI3K and MAPK pathways.24 Here, IGF2 is linked to glioblastoma.